| | | NPSG14-251 | | Rail in the West | | MP3 | | $20.00 | | $20.00 | |
| | | RHR08-210 | | Plenary: Religious Jew, Secular Zionist: Thoughts on Jewish Theology and Israel Speakers: Rabbi Arthur Green | | MP3 | | $10.00 | | $10.00 | |
| | | APSA25-525 | | Panel 12: Panel Honoring the Legacy of Mary Main: Clinical Applications of Attachment Theory to Psychoanalysis Speakers: Chair: Seth Aronson, Psy.D. | | MP3 | | $20.00 | | $20.00 | |
| | | NHF12-108 | | Helping Parents Manage Difficult Behaviors in Children with Hemophilia Speakers: Nathan J. Blum, MD; Moderator: Eric Iglewski, LMSW This session helps clinicians to counsel parents whose chronically ill children are exhibiting difficult behaviors. Factors that contribute to difficult behaviors will be reviewed. The importance of helping parents identify priorities for behavior change is emphasized and strategies for counseling parents to help their children increase desired behaviors are described. | | MP3 | | $10.00 | | $10.00 | |
| | | RHR08-116 | | Muslim Texts on Human Rights Speakers: Prof. Munther Dajani | | MP3 | | $10.00 | | $10.00 | |
| | | RHR08-150 | | The Second Raphael Human Rights Awards Speakers: Honorees: Marian Wright Edelman, Peter Edelman, and Rabbi Gerry Serotta. Award Presenters: Rabbi David Saperstein, Daniel Schorr, and Rabbi David Ellenson. Master of Ceremonies: Rabbi Amy Eilberg. | | MP3 | | $10.00 | | $10.00 | |
| | | RHR08-133 | | Honor the Image of God: Jewish Texts on the Torture Crisis Speakers: Rabbi Jeremy Kalmonofsky | | MP3 | | $10.00 | | $10.00 | |
| | | GenSpec11-301 | | The Doctors Are In Speakers: Jennifer Hastings, MD; Jennifer Burnett, MD | | MP3 | | $10.00 | | $10.00 | |
| | | GenSpec11-231 | | "Gender Born, Gender Made" book reading, with Author Diane Ehrensaft, PhD | | MP3 | | $10.00 | | $10.00 | |
| | | NHF12-103 | | Global Blood Safety, Optimizing Treatment and the Affordability of Care Speakers: Brian O’Mahony, Mark W. Skinner Over the next few years, we will see a revolution in treatment not seen since the 1960s. Treatment products will advance on all fronts, from viral-inactivated (solvent detergent) cryoprecipitate, biosimilars of current therapies and treatment products with substantially enhanced efficacy to the increasing likelihood that through gene transfer a “cure” may become a reality. The blood safety concerns of the past have been replaced by current concerns about maintaining vigilance against such blood-borne agents as viruses and prions. Equally important are the challenges of adequate factor supply and access to products around the world. This session describes how patients have started to join forces to bring all key stakeholders together to ensure that the views of product users are considered when it comes to access to these vital therapies. During this session we also address the challenges of answering US government and payer demands for evidence-based medicine, and cost justification for the introduction of new therapies and enhancement of current treatments. | | MP3 | | $10.00 | | $10.00 | |
 |
| Subtotal | | $120.00 |
